Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OraVerse for Reversal of Bupivacaine Anesthesia
NCT02995291Phase 4Completed
- Sponsor
- Dalhousie University
- Start
- Feb 2017
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of phentolamine in local anesthesia (2 arms), sponsored by Dalhousie University. Primary endpoint: Time to reversal of local anesthesia at 8 hours. Started Feb 2017; status: completed.
02
Drugs
phentolamine
03
Conditions
local anesthesia
Beyond the preview
Go deeper on NCT02995291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02995291.